REPL
Replimune Group Inc
Price:  
10.77 
USD
Volume:  
2,269,499.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-751.6%
Upside

As of 2025-07-11, the Relative Valuation of Replimune Group Inc (REPL) is (70.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.77 USD, the upside of Replimune Group Inc based on Relative Valuation is -751.6%.

The range of the Relative Valuation is (44.91) - (87.25) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.4x - 27.2x 20.3x
Forward P/E multiples 14.0x - 32.9x 23.4x
Fair Price (44.91) - (87.25) (70.17)
Upside -517.0% - -910.2% -751.6%
10.77 USD
Stock Price
(70.17) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 -2.93
2025-07-02 -2.98
2025-07-01 -2.85
2025-06-30 -2.90
2025-06-27 -2.91
2025-06-26 -2.95
2025-06-25 -2.95
2025-06-24 -3.04
2025-06-23 -2.88
2025-06-20 -2.89
2025-06-18 -2.96
2025-06-17 -2.96
2025-06-16 -3.06
2025-06-13 -3.05
2025-06-12 -3.08
2025-06-11 -3.05
2025-06-10 -3.16
2025-06-09 -3.17
2025-06-06 -3.24
2025-06-05 -3.04
2025-06-04 -3.02
2025-06-03 -3.00
2025-06-02 -2.98
2025-05-30 -2.80
2025-05-29 -2.92
2025-05-28 -2.63
2025-05-27 -2.62
2025-05-23 -2.60
2025-05-22 -2.73
2025-05-21 -2.64
2025-05-20 -2.86
2025-05-19 -2.56
2025-05-16 -2.45
2025-05-15 -2.25
2025-05-14 -2.19
2025-05-13 -2.31
2025-05-12 -2.45
2025-05-09 -2.40
2025-05-08 -2.42
2025-05-07 -2.23
2025-05-06 -2.34
2025-05-05 -3.12
2025-05-02 -3.12
2025-05-01 -3.01
2025-04-30 -3.05
2025-04-29 -2.93
2025-04-28 -2.89
2025-04-25 -2.82
2025-04-24 -2.82
2025-04-23 -2.75